- Investor's Business Daily•55 minutes ago
Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
- Investor's Business Daily•1 hour ago
The U.K. drug giant reported higher adjusted EPS even as sales continued to fall. AstraZeneca is pinning its hopes on a key immunotherapy drug trial.
- Investor's Business Daily•2 hours ago
Celgene reported better-than-expected first-quarter earnings, but sales were a little light, following similar results from fellow biotech giant Amgen late Wednesday.
AZN : Summary for Astrazeneca PLC Common Stock - Yahoo Finance
AstraZeneca PLC (AZN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||30.52 - 31.07|
|52 Week Range||25.55 - 35.04|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||22.36|
|Dividend & Yield||1.90 (6.30%)|
|1y Target Est||N/A|